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Arrhythmogenic right ventricular cardiomyop-
athy (ARVC; Online Mendelian Inheritance in 
Man accession no. 107970) is a clinically and 
genetically heterogeneous cardiac inherited dis-
order estimated to affect 1:2,000–5,000 indi-
viduals and is associated with increased risk of 
sudden death (Marcus et al., 1982; Thiene   
et al., 1988; Marcus et al., 2007; Basso et al., 
2009).  The  pathological  hallmark  of  ARVC 
consists of progressive, diffuse or segmental loss 
of cardiac myocytes. These are replaced by fibro-
fatty tissue predominantly in the right ventricle 
(RV), with aneurysm formation, chamber dila-
tation, and impaired cardiac function (Thiene 
et al., 1988; Basso et al., 1996). Clinical charac-
teristics  of  the  disease  comprise  left  bundle 
branch block morphology ventricular arrhyth-
mias, frequently associated with syncope or 
sudden cardiac death. Disease onset typically 
occurs in teenage years or young adulthood. It 
particularly affects athletes, in whom it is be-
lieved to be responsible for up to 20% of sud-
den cardiac death cases (Corrado et al., 2006).
Nearly  half  of  ARVC  probands  harbor 
one  or  more  mutations  in  genes  encoding 
major components of cardiac desmosomes, in-
cluding plakoglobin, desmoplakin, plakophilin-2,   
desmoglein-2  (DSG2),  and  desmocollin-2 
(Rampazzo et al., 2002; Gerull et al., 2004; 
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Mutations in the cardiac desmosomal protein desmoglein-2 (DSG2) are associated with 
arrhythmogenic right ventricular cardiomyopathy (ARVC). We studied the explanted heart 
of a proband carrying the DSG2-N266S mutation as well as transgenic mice (Tg-NS) 
with cardiac overexpression of the mouse equivalent of this mutation, N271S-dsg2, with 
the aim of investigating the pathophysiological mechanisms involved. Transgenic mice 
recapitulated the clinical features of ARVC, including sudden death at young age, spon-
taneous ventricular arrhythmias, cardiac dysfunction, and biventricular dilatation and 
aneurysms. Investigation of transgenic lines with different levels of transgene expression 
attested to a dose-dependent dominant-negative effect of the mutation. We demon-
strate for the first time that myocyte necrosis is the key initiator of myocardial injury, 
triggering progressive myocardial damage, including an inflammatory response and mas-
sive calcification within the myocardium, followed by injury repair with fibrous tissue 
replacement, and myocardial atrophy. These observations were supported by findings in 
the explanted heart from the patient. Insight into mechanisms initiating myocardial 
damage in ARVC is a prerequisite to the future development of new therapies aimed at 
delaying onset or progression of the disease.
© 2009 Pilichou et al.  This article is distributed under the terms of an Attribu-
tion–Noncommercial–Share Alike–No Mirror Sites license for the first six months 
after the publication date (see http://www.jem.org/misc/terms.shtml). After six 
months it is available under a Creative Commons License (Attribution–Noncom-
mercial–Share Alike 3.0 Unported license, as described at http://creativecommons 
.org/licenses/by-nc-sa/3.0/).
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later. During follow-up, she had progression of the disease with 
T wave inversion up to V5 and low QRS voltages on 12-lead 
ECG, and decreasing RV function (RVEF: 35%) in addition to 
signs of LV involvement on echocardiography (LVEF: 47%; 
Fig. 1, A and B). Moreover, the patient experienced several 
episodes of sustained VT and developed signs and symptoms of 
heart failure at the age of 63. Renal function remained normal 
until the last follow-up. Because of refractory heart failure, she 
eventually underwent successful heart transplantation at the age 
of 65. Clinical and genetic data on family members have been 
reported previously (Pilichou et al., 2006).
Pathological findings in the explanted heart of the proband
The explanted heart of the proband revealed increased heart 
weight (450 g), biventricular chamber dilatation (Fig. 1 C), 
wall thinning (RV free-wall thickness, 1 mm; LV free-wall 
thickness, 7 mm; ventricular septum thickness, 10 mm), and 
RV aneurysms at the inflow, apex, and outflow regions with 
endocardial thrombosis, in the presence of normal epicardial 
coronary arteries. Histologically, diffuse myocardial atrophy 
with fibro-fatty replacement was evident, which extended 
transmurally throughout the RV free wall and was confined 
to the subepicardial and midmural layers of the LV free wall 
(Fig. 1, D–F). The residual myocytes showed hypertrophy 
with dysmorphic and dysmetric nuclei. Spots of calcification 
(Fig. 1 G) were evident both in the RV and LV myocar-
dium, typically within areas of dense fibrous tissue. Scanty 
inflammatory infiltrates, consisting mostly of T lymphocytes, 
were also observed.
Generation of transgenic mice with cardiac-restricted 
expression of N271S-dsg2
We generated transgenic mice with cardiac-specific over-
expression of FLAG-tagged WT dsg2 (Tg-WT) and N271S-
dsg2 (Tg-NS). Two founders were obtained for Tg-WT and 
three founders for Tg-NS. Offspring from one of the Tg-WT 
founders and two of the Tg-NS founders were used in this 
study. The two Tg-NS lines studied differed in their level of 
expression of N271S mutant FLAG-tagged dsg2 and were 
designated Tg-NS/H (high expression) and Tg-NS/L (low 
expression; Fig. S1 A). The cardiac expression level of FLAG-
tagged WT dsg2 in the Tg-WT line studied was similar to 
Tg-NS/H. Confocal microscopy on cryosections of cardiac 
tissue stained with anti-FLAG antibody demonstrated proper 
localization of FLAG-tagged dsg2 to the intercalated discs in 
all three mouse lines studied (Fig. S1 B).
Sudden death occurred in 30% of mice with high expres-
sion of N271S-dsg2 (Tg-NS/H) by the age of 3.6 wk, and 
only 20% of Tg-NS/H mice survived by the age of 20 wk 
(Fig. 2 A). In contrast, mice expressing lower levels of 
N271S-dsg2 (Tg-NS/L) died at an older age (30% incidence 
of sudden death by the age of 6.2 wk).
ECG
Representative examples of surface ECG recordings from WT, 
Tg-WT, and Tg-NS/H mice are depicted in Fig. 2 (B and C), 
Pilichou et al., 2006; Syrris et al., 2006; Asimaki et al., 2007). 
Inheritance is mainly autosomal dominant with variable pen-
etrance and expressivity. Homozygous mutation in the plak-
oglobin gene causes Naxos disease, whereas homozygous 
mutation  in  the  desmoplakin  gene  underlies  Carvajal  syn-
drome, both characterized by ARVC associated with hair and 
skin abnormalities (McKoy et al., 2000; Norgett et al., 2000).
Despite recent discoveries on the genetic basis of ARVC, 
the etiopathogenesis of the disease remains poorly under-
stood. Different mechanisms have been proposed to underlie 
the ARVC phenotype. In earlier years, the disontogenetic 
(dysplastic), the degenerative (dystrophic), and the inflamma-
tory theories have been suggested (Thiene et al., 1991; Basso 
et al., 1996). In addition, cardiomyocyte apoptosis has been 
associated with ARVC, but the contribution of programmed 
cell death in disease onset (Mallat et al., 1996; Valente et al., 
1998) and progression remains unclear. In 2006, three animal 
models were generated in an attempt to define pathogenetic 
mechanisms of ARVC. These genetically engineered mice 
supported the transdifferentiation theory, the impairment of 
desmosomal function theory, and the role of environmental 
contribution to disease expression, respectively (Garcia-Gras 
et al., 2006; Kirchhof et al., 2006; Yang et al., 2006). However, 
the sequence of cellular events characterizing disease onset 
and progression remains unexplored.
We have previously identified the DSG2-N266S muta-
tion in a small kindred with ARVC (Pilichou et al., 2006). 
The N266 residue, located between the second and third 
extracellular cadherin domains of DSG2, has been shown to 
be critical for coordination of Ca2+ binding, a phenomenon 
essential to the adhesive intercellular interactions of junc-
tional cadherins. In the present study, we have analyzed a 
mouse model with overexpression of the mouse homologue 
of this mutation, N271S-dsg2, and investigated the explanted 
heart of the proband with the N266S mutation, enabling 
comparison of clinicopathological findings with the animal 
model. We demonstrate for the first time that myocyte 
necrosis is a key initiator of myocardial injury in ARVC, 
triggering progressive myocardial damage.
RESULTS
Clinical features in the proband carrying  
the DSG2-N266S mutation
The proband, a 55-yr-old female at diagnosis, was hospitalized 
for an episode of sustained ventricular tachycardia (VT) with 
left bundle branch block morphology that was hemodynami-
cally well tolerated. 12-lead electrocardiography (ECG) showed 
sinus rhythm with first-degree atrioventricular block and nega-
tive T waves in V1–V3. Signal-averaged ECG demonstrated 
late potentials at all filter settings (25, 40, and 80 Hz). Two-
dimensional echocardiography and ventricular angiography dis-
played severe RV dilatation with a mildly depressed function 
(RV ejection fraction [RVEF]: 48%), whereas left ventricle 
(LV) parameters were within normal limits. Normal, patent 
coronary arteries were observed at coronary angiography. The 
patient received an implantable cardioverter-defibrillator a year JEM VOL. 206, August 3, 2009 
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in either heart rate (RR interval), PR duration, or QTc   
interval were observed. Tg-NS mice also displayed signifi-
cantly more spontaneous arrhythmias compared with WT 
and Tg-WT mice. Tg-NS mice displayed frequent premature 
and the main electrocardiographic data are reported in Fig. 2 D 
and Table S1. At an average age of 6 wk, Tg-NS/H 
mice displayed significantly increased QRS duration com-
pared with WT and Tg-WT mice, whereas no differences   
Figure 1.  Characteristics of the female patient carrier of the DSG2-N266S mutation who underwent heart transplantation at the age of 65. 
(A) 12-lead ECG 2 mo before heart transplantation displaying sinus rhythm with PQ and QT prolongation, intraventricular conduction delay, and nega-
tive T wave V1–V4. (B) Two-dimensional echocardiography showing biventricular dilatation. (C) Gross view of the explanted heart specimen showing 
massive RV dilatation with RV outflow tract aneurysm. Bar, 1 cm. (D and E) RV and LV free wall showing fibro-fatty replacement of the myocardium 
with almost total disappearance of the myocardium in the RV. Bar, 5 mm. (F) Close-up of E. Bar, 30 µm. (G) At higher magnification, spotty calcification 
is observed in areas of replacement-type fibrosis. Bar, 50 µm.1790 MYOCYTE NECROSIS IN ARRHYTHMOGENIC RIGHT VENTRICULAR CARDIOMYOPATHY | Pilichou et al.
but  developed  significant  QRS  prolongation  only  with 
advanced age, thus displaying a phenotype of intermediate 
severity (Table S2). Interestingly, Tg-NS/L mice displayed 
spontaneous arrhythmias already at young age in the pres-
ence of normal ECG indices (Table S1).
Cardiac morphology and function in vivo
Representative M-mode and two-dimensional echocardio-
grams performed in 12-wk-old mice are shown in Fig. 3 A. 
The main echocardiographic data are reported in Fig. 3 B 
and Table S3. Tg-NS/H mice showed increased RV and 
LV end-diastolic and -systolic diameters and increased RV 
end-diastolic area. LV fractional shortening was significantly 
reduced in Tg-NS/H compared with Tg-WT and WT mice. 
Tg-NS/L mice demonstrated a phenotype of intermediate 
severity (Table S3).
Conduction slowing and arrhythmia inducibility  
in isolated hearts
Data from epicardial mapping experiments performed on iso-
lated Langendorff-perfused hearts are reported in Fig. 4 and 
Table S4. In hearts from Tg-NS/H mice, both RV and LV 
showed abnormal activation patterns in addition to crowding 
of isochrones, indicating the presence of conduction block 
(Fig. 4 A). During sinus rhythm, total ventricular activation 
time was significantly increased in both RV and LV of 
Tg-NS/H as compared with WT and Tg-WT mice (Fig. 4 E). 
When the hearts were stimulated from the center of the elec-
trode at a basic cycle length of 120 ms, total activation time 
was greatly increased in LV of Tg-NS/H mice, whereas there 
was only a trend toward increased activation time observed 
for the RV (Fig. 4 E). Excessive conduction slowing in 
Tg-NS/H hearts was further associated with fractionation of 
the extracellular electrogram, a feature not observed in WT 
or Tg-WT hearts (Fig. 4 B). Tg-NS/H hearts also displayed 
increased inducibility of ventricular arrhythmias as compared 
with WT and Tg-WT hearts, both in LV and RV (Fig. 4, C, D, 
and F). A phenotype of intermediate severity was again ob-
served on epicardial mapping in Tg-NS/L compared with 
Tg-NS/H hearts (Table S4).
Gross cardiac morphology
Main cardiac features and gross morphology data from the 
different study groups are displayed in Fig. 5. Gross mor-
phological examination of the hearts from Tg-NS/H mice 
did not reveal any pathological change in mice younger than 
2 wk (Fig. 5 A, a). In 3–5-wk-old Tg-NS/H mice, hearts 
were increased in weight and displayed whitish streaks in the 
subepicardial myocardium (Fig. 5 A, b). Progressive thin-
ning of both the LV and the RV free walls was found with 
increasing age in Tg-NS/H mice. Moreover, Tg-NS/H 
mice >5 wk old showed RV and LV chamber dilatation and 
biventricular aneurysms (Fig. 5 A, c). With increasing age, 
Tg-NS/H hearts displayed significant increments of heart 
weight to body weight (HW/BW) ratio and cardiomyocyte 
diameter, and significant reduction of RV, LV, and ventricular 
ventricular  beats,  monomorphic  and  polymorphic  VT,   
and atrial arrhythmias (Fig. 2 C), whereas WT and Tg-WT 
mice showed only sporadic atrial premature beats. In con-
trast  to  Tg-NS/H  mice,  those  from  the  Tg-NS/L  line 
showed no differences in ECG parameters at the age 6 wk 
Figure 2.  Characteristics of transgenic mice with cardiac-restricted 
expression of N271S-dsg2. (A) Kaplan-Meier survival plot of Tg-NS/H 
(blue line; n = 225), Tg-NS/L (red line; n = 156), and Tg-WT (green line; 
n = 129) mice. Note the high death rate in the mutant lines, with 30% of 
death occurring by 3.6 wk in Tg-NS/H mice. (B) Examples of surface ECG 
measurements from WT, Tg-WT, and Tg-NS/H mice showing prolongation 
and fractionation of the QRS complex, indicating impairment of ventricu-
lar conduction. Bar, 25 ms. (C) Typical ECG examples of spontaneous ven-
tricular arrhythmias observed in Tg-NS/H mice. Bar, 500 ms. (D) Mean 
values of ECG parameters including heart rate (HR), PR and QRS intervals, 
and incidence of spontaneous arrhythmias. Data represent means ± SEM 
measured from >200 consecutive beats from single independent ECG 
measurements in 17 WT, 12 Tg-WT, and 15 Tg-NS/H mice (#, P < 0.05 vs. 
WT; $, P < 0.05 vs. Tg-WT; Table S1).JEM VOL. 206, August 3, 2009 
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Fig. 8, A and B) but not in Tg-WT and WT mice of the 
same age. In 3–5-wk-old Tg-NS/H mice, extensive myo-
cyte necrosis and massive calcification were a constant fea-
ture in both RV and LV; granulation tissue and early loose 
connective tissue deposition were also evident (Fig. 6, G–I; 
and Fig. 7 C). Typically, myocardial damage started in the 
outer subepicardial layers (Fig. 6, D–F), with progressive 
extension toward the endocardium to become transmural 
by 4 wk (Fig. 6, G–I).
As revealed by trichrome staining, dense fibrosis with 
collagen bundle formation and aneurysm appeared in all 
septum wall thickness (Fig. 5 B). In line with previous 
observations (see above), Tg-NS/L hearts again showed an 
intermediate severity phenotype (Table S5).
Histological abnormalities
Trichrome, hematoxylin-eosin (H&E), and von Kossa stain-
ing on heart sections revealed no abnormalities in Tg-NS/H 
mice <2 wk old (Fig. 6, A–C; and Fig. 7 A). Spotty con-
traction band and coagulative necrosis, followed by massive 
inflammatory infiltrates, were evident in the myocardium 
of 2–3-wk-old Tg-NS/H mice (Fig. 6, D–F; Fig. 7 B; and 
Figure 3.  Assessment of in vivo cardiac morphology and function. (A) M-mode and two-dimensional echocardiography in WT, Tg-WT, and Tg-NS/H 
mice displaying LV and RV chamber dilatation in mutant mice. (B) Mean values of echocardiographic parameters from WT, Tg-WT, and Tg-NS/H mice, 
including LV and RV end-diastolic diameter (LVEDD and RVEDD, respectively), LV and RV end-systolic diameter (LVESD and RVESD, respectively), RV area 
(RV area in diastole [short-axis view]), and LV fractional shortening (LVFS). Data represent means ± SEM from single independent echocardiographic mea-
surements on five mice per experimental group (#, P < 0.05 vs. WT; *, P < 0.001 vs. WT; $, P < 0.01 vs. Tg-WT; &, P < 0.001 vs. Tg-WT; Table S3).1792 MYOCYTE NECROSIS IN ARRHYTHMOGENIC RIGHT VENTRICULAR CARDIOMYOPATHY | Pilichou et al.
myocyte necrosis (not depicted). No adipocytes were observed, 
both at early and late stages of disease.
Consistent with death at older age and the later de-
velopment of echocardiographic and electrophysiological   
abnormalities, Tg-NS/L hearts showed a morphological phe-
notype of intermediate severity compared with Tg-NS/H 
Tg-NS/H mice >5 wk old (Fig. 6, J and M; and Fig. 7 D) 
but not in aged-matched Tg-WT and WT controls. Nuclear 
abnormalities (dysmetric and dysmorphic) were also evident 
in later stages.
Oil red O staining of thin myocardial sections showed 
focal lipid droplet accumulation, typically within the areas of 
Figure 4.  Epicardial mapping experiments in Langendorff-perfused hearts. (A) Examples of RV and LV activation maps for WT, Tg-WT, and Tg-NS/
H hearts during sinus rhythm (SR) and stimulation from the center of the electrode (stim). Crowding of isochrones in Tg-NS/H hearts indicates areas of 
conduction slowing. (B) Examples of extracellular electrograms showing fractionation of the extracellular signal (a sign of excessive conduction slowing) 
in Tg-NS/H but not in WT or Tg-WT mice. (C) Induction of VT in a Tg-NS/H heart after administration of two short-coupled extrastimuli (S1 and S2).  
(D) Ventricular activation map during beats 1–3 of the VT depicted in C. (E) Mean RV and LV activation times during SR and central stimulation (CS). (F) Mean 
incidence of inducible arrhythmias. Data represent means ± SEM from single independent epicardial mapping experiments from five WT, six Tg-WT, and 
five Tg-NS/H mice (#, P < 0.05 vs. WT; ‡, P < 0.01 vs. WT; $, P < 0.05 vs. Tg-WT; Table S4).JEM VOL. 206, August 3, 2009 
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Figure 5.  Gross features of explanted mouse hearts. (A) Tg-NS/H, Tg-WT, and WT hearts at age <2 (a, d, and g), 5 (b, e, and h), 10 (c, f, and i) wk. 
Note the structurally normal hearts at young age, with later appearance of calcification and dilatation with aneurysms (arrows) in Tg-NS/H hearts. Bars: 
(a, b, and d–i) 1 mm; (c) 2 mm. (B) Mean values of HW/BW ratios; LV, RV, and ventricular septum (VS) wall thicknesses; and cardiomyocyte diameters in 
hearts of different age groups (<3, 3–6, and 6–12 wk; 10 mice per age group for each line; #, P < 0.01 vs. WT; ‡, P < 0.01 vs. Tg-WT; Table S5).
hearts. These mice developed significant histological abnor-
malities only at older age (>5 wk) and showed lower preva-
lence of calcification, indicating a slower development of 
the phenotype.
Assessment of necrosis
Necrosis was the first manifestation of disease in all Tg-NS 
hearts studied. Electron microscopic evaluation in 2–3-
wk-old Tg-NS/H mice showed ultrastructural features in 1794 MYOCYTE NECROSIS IN ARRHYTHMOGENIC RIGHT VENTRICULAR CARDIOMYOPATHY | Pilichou et al.
of necrotic myocytes were seen as scattered dense masses of 
mineralized debris with surrounding collagen bundles and 
occasional macrophages (Fig. 8 F).
To  determine  whether  disruption  of  the  sarcolemmal 
membrane occurred in the intact hearts of young (2–3 wk old) 
Tg-NS/H mice, we evaluated sarcolemmal integrity in vivo by 
injecting Evans Blue dye (EBD), a large tracer molecule that 
can only enter myocytes with a disrupted sarcolemma. Uptake 
of EBD was observed in the myocardium of Tg-NS/H mice 
but was absent in Tg-WT and WT mice (Fig. 9).
keeping with cardiomyocyte necrosis, i.e., disruption of the   
sarcolemma, disgregation of myofilaments and other cyto-
plasmic elements, and mitochondrial swelling. Multiple   
amorphous  matrix  densities  were  observed  in  swollen   
mitochondria (Fig. 8, C and D). Some mitochondria also 
exhibited  electron-dense  calcific  deposits  and  complete   
mineralization preceding calcification of cardiomyocytes 
(Fig. 8 E). Calcified cardiomyocytes were then phagocy-
tosed  by  macrophages  with  typical  lysosomal  bodies.  In 
older mice with advanced myocardial lesions, the remnants 
Figure 6.  Histological features of explanted hearts from Tg-NS/H mice. (A–O) Heidenhain trichrome, H&E, and von Kossa staining of transverse 
full sections of the hearts at different ages: <2 (A–C), 2.7 (D–F), 3.6 (G–I), 8 (J–L), and 12 (M–O) wk. Note the appearance of myocardial damage in the 
outer subepicardial layers with calcification in both RV and LV free walls after 2 wk of age, with progressive extension to become transmural by 4 wk 
of age, and deposition of mature fibrosis with wall thinning and aneurysm formation by 8 wk of age. Bars: (A–C) 0.5 mm; (D–F) 0.8 mm; (G–I) 0.5 mm; 
(J–L) 0.4 mm; and (M–O) 0.8 mm.JEM VOL. 206, August 3, 2009 
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level of the intercalated discs of desmosomal proteins (desmo-
plakin, desmoglein-2, plakoglobin, and plakophilin-2), as well 
as desmin and connexin43 (unpublished data).
DISCUSSION
Transgenic mice overexpressing dsg2-N271S, the mouse 
homologue of the DSG2-N266S mutation found in a family 
with ARVC, recapitulate the pathognomonic features of the 
human disease, including sudden death, spontaneous ventric-
ular arrhythmias, ECG characteristics of conduction slowing, 
cardiac dysfunction, ventricular dilatation and aneurysms, 
myocardial atrophy, and fibrosis. In this model, which is the 
first dsg2-related mouse model of ARVC, we provide evi-
dence that the ARVC phenotype, although genetically deter-
mined, develops postnatally and is progressive with age. We 
demonstrate for the first time that it is initiated by necrotic 
cell death, which subsequently triggers an inflammatory 
response and massive calcification within the myocardium, 
followed later by injury repair with fibrous tissue replace-
ment. Our data bring to the fore hitherto underexposed 
aspects in the pathogenesis of ARVC. Insight into the mech-
anism of disease enables research into new therapies aimed at 
delaying onset and progression of ARVC.
Cardiac desmosomes and DSG2
Cardiac desmosomes are intercellular junctions at the in-
tercalated discs of cardiomyocytes, closely apposed to gap 
Assessment of apoptosis
Terminal  deoxynucleotidyl  transferase–mediated  dUTP 
nick-end  labeling  (TUNEL)  analysis  in  2–3-wk-old  mice 
demonstrated low levels of positive cells in Tg-NS/H mice 
(Fig. 10 A). These were usually confined close to areas of 
myocyte necrosis and/or fibrous tissue replacement. A higher 
TUNEL index was found in Tg-NS/H mice compared with 
WT and Tg-WT mice at >6 wk of age.
Immunostaining with anticleaved caspase-3 antibody at 
>2 wk of age showed the presence of apoptotic cells in 
Tg-NS/H hearts, but again only in necrotic areas (Fig. 10 B). 
In contrast, at <2 wk of age, only sporadic cleaved caspase-3 
positivity was observed, indicating that apoptosis did not pre-
cede the development of necrosis. Western blot analysis on 
cardiac tissue from 3- and 6-wk-old mice did not reveal an 
increment of cleaved caspase-3 levels in Tg-NS/H compared 
with Tg-WT and WT mice (unpublished data).
Assessment of intercalated discs
Electron microscopic evaluation of younger (<2 wk old) and 
older Tg-NS/H mice showed structurally normal desmosomes 
distributed along the intercalated discs, even in the setting of 
myocyte necrosis, that were similar to those of age-matched 
Tg-WT and WT hearts. In particular, no widened gaps of 
intercalated discs were observed in Tg-NS/H mice (Fig. S2). 
Immunohistochemical assessment by confocal microscopy of 
Tg-NS/H myocardium showed a normal distribution at the 
Figure 7.  Histological features of Tg-NS/H hearts at high magnification. (A) Normal myocardium (1.7 wk of age). Bar, 50 µm. (B) Cardiomyocyte 
necrosis with early neutrophil infiltrates (2.1 wk of age). Bar, 20 µm. (C) Diffuse inflammatory cells including macrophages (3.6 wk of age). Bar, 50 µm.  
(D) Replacement-type fibrosis with spots of calcification (8 wk of age). Bar, 30 µm.1796 MYOCYTE NECROSIS IN ARRHYTHMOGENIC RIGHT VENTRICULAR CARDIOMYOPATHY | Pilichou et al.
Troyanovsky et al., 1993; Chitaev and Troyanovsky, 1997). 
Adhesion of cadherins originating from adjacent cells oc-
curs through interaction of extracellular cadherin domains 
(ectodomains) that form the rodlike extracellular portion of 
the protein. Successive ectodomains are interconnected by 
sequences that dock three Ca2+ ions (Nagar et al., 1996). 
Structural and biochemical interaction studies of cadherin 
ectodomains have demonstrated the importance of Ca2+ 
binding at these sites in adhesive intercellular interactions of 
these domains, providing structural rigidity necessary for rec-
ognition and assembly of trans (adhesive) cadherin junctions 
junction plaques, which confer mechanical coupling of the 
myocytes in the heart through families of proteins including 
the desmosomal cadherins, armadillo, and plakins (Stokes, 
2007). The desmosomal cadherins (desmogleins and demo-
collins)  are  single  transmembrane  glycoproteins,  which 
mediate  Ca2+-dependent  homophilic  interactions  between 
the extracellular regions of these proteins emanating from 
opposing cell surfaces. The intracellular domain of desmo-
somal cadherins binds to two proteins of the armadillo fam-
ily, namely plakoglobin and plakophilin, forming an indirect 
link to desmoplakin and the intermediate filaments (desmin; 
Figure 8.  Ultrastructural features of cardiomyocyte necrosis in Tg-NS/H mice. (A) Focal contraction band necrosis on a semithin section. Bar, 
10 µm. (B) Myocytolysis on a semithin section. Bar, 10 µm. (C) Disgregation of cytoplasm with loss of myofilaments and woolly bodies inside swollen mito-
chondria (m), features in keeping with necrotic cell death. Bar, 500 nm. (D) Loss of sarcolemma integrity in a cardiomyocyte (black arrow) with cytoplas-
mic disgregation, close to abnormal cardiomyocyte with intact sarcolemma (white arrow). Bar, 500 nm. (E) Mineralization of mitochondria. Bar, 2 µm. 
(F) Spotty calcification within fibrous tissue on a semithin section. Bar, 10 µm.JEM VOL. 206, August 3, 2009 
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change associated with amino acid substitution in a key pro-
tein function domain is alone able to reproduce the main 
clinical and pathological features of ARVC, whereas hetero-
zygous gene knockout does not result in disease phenotype 
(Ruiz et al., 1996; Grossmann et al., 2004). These data are 
consistent with a dose-dependent dominant-negative effect of 
the N271S-dsg2 mutation on cell integrity and ARVC phe-
notype in transgenic mice, whereas haploinsufficiency alone 
may not be sufficient to cause disease.
Myocyte necrosis is a key initiator of myocardial dystrophy
Our experimental model for the first time provides evidence 
that necrotic myocyte death is the initiating event in the 
myocardial injury and repair process. Necrosis always pre-
ceded other pathological signs of disease, such as inflam-
mation and calcification, and later on, fibrosis, ventricular 
dilation, and aneurysm formation. Furthermore, myocyte 
necrosis originated in the subepicardial myocardium, followed 
(Chitaev and Troyanovsky, 1998; Sotomayor and Schulten, 
2008). It has been previously shown that point mutation of 
amino acid residues directly involved in coordinating Ca2+ 
at successive sites between individual ectodomains results in 
loss of adhesive (trans) intercellular interaction of dimers and 
favors lateral interaction of ectodomains stemming from the 
same cell (cis-interaction; Klingelhöfer et al., 2002). Resi-
due N266 (N271 in mouse) of DSG2, located between the 
second and third cadherin ectodomains, represents one of 
these critical Ca2+ coordinating residues (Fig. S3). We ob-
served, however, structurally normal desmosomes both in 
the human ARVC patient and in Tg-NS/H mice, similar 
to those observed in WT and Tg-WT mice, without any 
evidence of gap widening. This is in line with a dominant-
negative effect of mutant DSG2 on desmosome function 
rather than structure.
An interesting observation from the engineering of mu-
tant mice for desmosomal proteins is that a single nucleotide 
Figure 9.  Immunohistochemical analysis of cardiac cryosections from 2–3-wk-old mice injected with EBD. (A and B) WT and Tg-WT hearts 
show normal distribution of desmin, dystrophin, and pan-cadherin in the ventricles, and no EBD-positive cells. Bars, 250 µm. (C and D) In contrast, hearts 
from Tg-NS mice display large areas of ventricular myocardium lacking desmin, dystrophin, and pan-cadherin. These abnormal areas contained myocytes 
positive for EBD, indicating increased cell membrane permeability and loss of myocyte integrity and viability. Bars: (C) 250 µm; (D) 50 µm.1798 MYOCYTE NECROSIS IN ARRHYTHMOGENIC RIGHT VENTRICULAR CARDIOMYOPATHY | Pilichou et al.
mural distribution of myocardial fiber architecture and/or   
of wall mechanics may play a role. Apoptosis was also ob-
served in hearts from Tg-NS mice of different ages, but to a 
smaller extent and usually confined to areas of necrosis or 
fibrosis, indicating that, although apoptosis can contribute 
to progressive cardiomyocyte atrophy (Valente et al., 1998), 
by a wave-front extension toward the endocardium. This 
wave-front phenomenon of myocardial atrophy is well docu-
mented in human ARVC, both by histopathologic examina-
tions and cardiac magnetic resonance studies (Sen-Chowdhry 
et al., 2008; Basso et al., 2009). The underlying mechanism 
for this remains unknown, although heterogeneity in trans-
Figure 10.  Cardiomyocyte apoptosis in Tg-NS/H mice. (A, left) TUNEL analysis of cardiac apoptosis. Note the presence of positive-stained myocyte 
nuclei (brown) close to an area of myocyte necrosis. (inset) Close-up of boxed area. Bar, 50 µm. (right) Mean values are depicted for the percentage of 
TUNEL-positive cells in three age groups. Data in this figure are representative of 7 WT, 8 Tg-WT, and 10 Tg-NS/H mice. #, P < 0.05 vs. WT and Tg-WT. (B) Immuno-
histochemical analysis of cleaved caspase-3 (CC3) for assessment of apoptosis in cardiac cryosections from Tg-NS mice. In Tg-NS mice <2 wk old (1.7 wk old in 
this example), cardiac structure was still unaltered, as indicated by the normal -actinin staining pattern, and CC3-positive cells were hardly observed.  
In contrast, in hearts of Tg-NS mice of >2 wk old, clear CC3 staining was observed, but only in necrotic areas of the ventricular myocardium. Bars, 50 µm.JEM VOL. 206, August 3, 2009 
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proteins. Although the mechanism by which mutant dsg2 
produces myocyte necrosis remains to be elucidated, one 
could hypothesize that desmosomal protein dysfunction af-
fects sarcolemma integrity and/or mithocondrial permeabil-
ity with abnormal calcium homeostasis.
Electrical instability, conduction disturbances,  
and biventricular involvement
Extensive investigation of the electrophysiological conse-
quences of overexpression of dsg2-N271S shows a highly 
arrhythmogenic phenotype, with a high prevalence of spon-
taneous ventricular arrhythmias. Crucially, arrhythmia induc-
ibility was greatly increased in both the RV and LV, in line 
with the observed biventricular disease involvement on echo-
cardiography, gross morphology, and histology. The biven-
tricular  involvement  is  not  an  unexpected  finding.  The 
proband with the N266S mutation had left ventricular abnor-
malities, and genotype–phenotype correlations in ARVC 
mutation carriers have shown a higher occurrence of LV 
involvement than previously thought, supporting the adop-
tion of the broader term “arrhythmogenic cardiomyopathy” 
(Basso et al., 2009).
Sudden death occurred in 30% of mice with high expres-
sion of N271S-dsg2 by the age of 3.6 wk, and only 20% of 
Tg-NS/H mice survived by the age of 20 wk. Thus, prema-
ture death occurs not only in the advanced stages of the 
disease but also at young age, when there is as yet no mor-
phological evidence of the chronic fibrous repair with aneu-
rysm formation but only of the acute–subacute damage, with 
myocyte necrosis and inflammation. This again reproduces 
accurately the clinical course of human ARVC, where car-
diac arrest can manifest at every stage along the natural   
history (Nava et al., 2000). VT/fibrillation is usually the 
mechanism of instantaneous sudden death in the “hot phase” 
of disease progression, likely because of acute myocyte death 
and reactive inflammation (Basso et al., 2009). On the con-
trary, older patients with a long-lasting ARVC more often 
experience scar-related VT.
Conduction through the ventricles was clearly affected in 
Tg-NS mice, whereas sinoatrial and atrioventricular conduc-
tion were unaltered. The last finding also reproduces the 
human disease, in which conduction slowing has been proven 
to be typically parietal and not septal, because of fibro-fatty 
replacement of the working myocardium of the ventricular 
free wall, not affecting the specialized conducting tissue.
Fatty tissue and ARVC mouse models
Clear-cut evidence of adipocytes was never observed neither 
in routine histology nor in ultrastructural investigation of the 
myocardium in Tg-NS mice both at early stages of disease 
onset and in later stages. Only focal neutral lipid accumula-
tion in areas of ongoing myocyte death was evident, suggest-
ing alteration of lipid metabolism. Noteworthy, this was also 
the case of previous ARVC experimental animal models 
(Garcia-Gras et al., 2006; Yang et al., 2006), which described 
only an excess accumulation of fat droplets, predominantly at 
necrosis appears to be the leading mechanism in disease onset 
and exacerbation.
Different from previously reported ARVC animal mod-
els,  in  which  only  the  characteristic  features  of  advanced 
ARVC were reported (Garcia-Gras et al., 2006; Yang et al., 
2006), in our dsg2 model we have performed, for the first 
time, a “step-by-step” investigation of histopathological changes 
occurring over time in the myocardium, starting from the 
stage in which the myocardium appeared normal, through 
the early stages of myocardial disease, and extending toward 
the late ARVC phenotype. Overall, this dsg2 animal model 
highlights hitherto underexposed aspects of ARVC. How-
ever, mutations in the DSG2 gene account for only a minor-
ity of ARVC patients, and the results of the present study 
may not necessarily be transferable to mutations in other 
ARVC genes that are much more frequent in the ARVC 
population (i.e., desmoplakin or plakophilin-2). Further 
studies are needed to assess whether our findings also hold 
true for other genetic forms of ARVC.
Necrosis has been rarely observed at postmortem analysis 
(Basso et al., 1996; Bauce et al., 2005). The fact that necrosis is 
not often reported in both autopsy and endomyocardial biopsy 
studies (Basso et al., 2008) of human ARVC likely relates to its 
focal distribution and possibly episodic nature, typically during 
disease onset or acute phases of disease progression. In the clin-
ical setting, environmental factors such as exercise or inflam-
mation have been advocated in facilitating disease onset and 
progression by worsening cell adhesion. In fact, human disease 
onset and progression is sometimes characterized by the onset 
of chest pain with electrocardiographic changes and myocar-
dial enzyme release, mimicking acute myocardial infarction so 
as to suggest underlying cardiomyocyte necrosis (Bauce et al., 
2005; Sen-Chowdhry et al., 2008; Basso et al., 2009).
Dystrophic myocardial calcification was detected both 
in Tg-NS mice and in the explanted human ARVC heart, 
and has been previously reported both in spontaneous ani-
mal models (Protonotarios and Tsatsopoulou, 2004) and in 
human ARVC (Basso et al., 2001). Although these observa-
tions may signify previous episodes of accelerated necrosis, 
we cannot exclude that dystrophic calcification in the fail-
ing heart of the N266S proband resulted from other poten-
tial causes beyond those that are integral to the underlying 
ARVC disease process. In addition, the magnitude of cal-
cification observed in the mouse may reflect an increased 
susceptibility to calcification caused by active bone mineral-
ization mechanisms in these young rapidly growing animals 
(Fatkin et al. 1999; Topaz, 1991).
So far, myocyte necrosis and dystrophy have been related 
to mutation in structural proteins linking the underlying con-
tractile proteins to the sarcolemma and the extracellular ma-
trix or those that stabilize or repair the cell membrane (Bansal 
et al., 2003; Lapidos et al., 2004). Our findings in Tg-NS 
mice, together with the presence of pronounced calcification 
as a sequela of previous necrosis in the explanted heart of the 
N266S proband, provide the first evidence that myocyte   
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and Tg-NS/L mice were compared with age-matched control WT and Tg-WT 
mice. Echocardiographic data and images were analyzed off-line by a 
researcher blinded to the genotype.
ECG measurements. 12-lead ECG in humans was performed according 
to previously reported methods (Nava et al., 2000). For surface ECG analy-
sis, mice were anaesthetized using isoflurane inhalation (induction 4 volume % 
in oxygen followed by maintenance 1–1.5 volume %). Four-lead surface 
ECGs were recorded from subcutaneous 23-gauge needle electrodes attached 
to each limb using the Powerlab acquisition system (ADInstruments). Leads 
I and II were analyzed for heart rate (RR interval) and PR, QRS, and QT 
duration using Chart5 Pro analysis software (ADInstruments). QT intervals 
in mice were corrected for heart rate using the following formula: QTc = 
QT/(RR/100)1/2 (RR in ms; Mitchell et al., 1998).
Epicardial mapping experiments. Mice were anesthetized by an intraperi-
toneal injection of pentobarbital, after which the heart was excised, cannu-
lated, and mounted on a Langendorff perfusion set-up, and epicardial mapping 
on the RV and LV was performed as previously described (Remme et al., 
2006). In short, ventricular extracellular epicardial electrograms were recorded 
during sinus rhythm and ventricular pacing at 120 ms and at twice the stimulus 
threshold from the center of the electrode. Inducibility of ventricular arrhyth-
mias was assessed using a stimulation protocol with up to three extrastimuli, 
followed by burst pacing at the shortest possible coupling intervals.
EBD uptake. 1% EBD (wt/vol; 1 mg /0.1ml PBS/10 mg body weight; 
Sigma-Aldrich) was administered intraperitoneally at the right side of the 
peritoneal cavity to 2–3-wk-old mice, after which the animals were returned 
to their cage and allowed food and water ad libitum. After 24 h, the mice 
were sacrificed and hearts were excised, snap-frozen in liquid nitrogen, and 
sectioned into 7-µm-thick cryosections. EBD was detected as red autofluo-
rescence under a fluorescent microscope (Han et al., 2007).
Morphological analysis. For pathological studies, hearts from 30 mice 
per line at different age groups were isolated and fixed in 10% phosphate-
buffered formalin (pH 7.35) for gross and histological examination. Macro-
scopic evaluation included assessment of chamber dilatation and aneurysms, 
and measurements of heart weight and wall thickness. 7-µm-thick paraffin-
embedded sections were serially cut and routinely stained by H&E to exam-
ine the myocardium, by Heidenhain trichrome and Sirius red for assessment 
of fibrosis, and by von Kossa for the detection of calcium.
Histomorphometric analysis to assess myocyte diameters was performed 
on samples stained with H&E using an image analyzer system and commer-
cially available software (Image-Pro Plus Version 4.0; Media Cybernetics) 
according to a previously described method (Basso et al., 2008).
Furthermore, freshly isolated, snap-frozen hearts from five mice per 
age group were mounted in Tissue-Tek Optimal Cutting Temperature 
compound (Sakura). 7–8-µm-thick myocardium cryosections were stained 
with Oil red O and counterstained with H&E to assess the presence of 
neutral lipids.
Ultrastructural  investigation.  Myocardial  samples  (LV  and  RV  sepa-
rately) were fixed in 2.5% glutaraldehyde in 0.1 mmol/liter of phosphate 
buffer (pH 7.3) and postfixed in buffered 1% osmium tetroxide for 1 h. 
Samples were dehydrated in a series of ethanol and embedded in epon. 
Semithin sections were first evaluated under light microscopy before pro-
ceeding with the ultrathin sections. Thin sections were stained with uranyl 
acetate and lead citrate and examined under an electron microscope (H-7000; 
Hitachi) equipped with a digital camera. Intercalated discs were assessed at 
final magnifications of 30,000 and 60,000 according to a standardized 
method (Basso et al., 2006).
Immunohistochemistry. Cardiac cryosections were prepared, treated, 
and stained for immunohistochemistry according to standard procedures. 
The following primary antibodies were used against FLAG (1:100; M5; 
Sigma-Aldrich), dsg2 (1:100; Progen), desmocollin-2 (1:100; S-14; Santa 
the site of fibrosis. The absence of adipose tissue in transgenic 
mice of ARVC might be caused by differences between spe-
cies, considering that the WT mouse does not show evidence 
of epicardial fat, which is different from the human heart, 
where there is always a physiological amount of fatty tissue in 
the subepicardium.
In conclusion, transgenic mice overexpressing the dsg2 
mutation N271S recapitulate pathognomonic features of 
human  ARVC.  Our  data  demonstrate  for  the  first  time   
that myocyte necrosis is a key initiator of myocardial dystro-
phy in dsg2-related ARVC and represent a starting point 
for further studies regarding the molecular mechanism of 
ARVC pathogenesis.
MATERIALS AND METHODS
Clinical evaluation of the ARVC patient. The study was approved by 
the  University  of  Padua  Medical  School–Azienda  Ospedaliera  ethical 
committee. Informed consent was obtained from the patient, and clinical 
evaluation consisted of a detailed personal/family history, physical exami-
nation, 12-lead ECG, two-dimensional echocardiography, signal-averaged 
ECG, and stress-test ECG, performed according to previously reported 
methods (Nava et al., 2000). The relatives of the proband were diagnosed 
based on the established European Society of Cardiology/International 
Society and Federation of Cardiology Task Force major and minor criteria 
(McKenna et al., 1994).
Generation of Tg-NS and Tg-WT mice. Dsg2 cDNA was amplified by 
RT-PCR from RNA isolated from cardiac tissue of FVB/N mice (Charles 
River Laboratories) using forward (5-TCCCGCAGAGTCAGAGAAG-3)   
and  reverse  (5-CTTATCGTCATCGTCCTTGATGTCACCTCCA-
CCTCCGGAGTAAGAATGTTGCATGGTG-3)  primers  designed 
to generate a FLAG epitope fused to the C terminus of DSG2 to enable 
localization of the transgene protein product and differentiation from the 
endogeneous dsg2. The nucleotide change leading to the N271S amino 
acid  substitution  was  introduced  by  site-directed  mutagenesis  using  the   
Quikchange  kit  (Agilent  Technologies)  and  the  following  primers:   
5-CCGTATATTGGATGTCAGTGACAATATACCTGTGG-3  and 
5-CCACAGGTATATTGTCACTGACATCCAATATACGG-3. WT 
and N271S mutant dsg2 cDNA (3.4 kb) were cloned into the -myosin 
heavy chain promoter construct (supplied by J. Robbins, Children’s Hos-
pital, Cincinnati, OH) for cardiac-specific overexpression. WT and mutant 
(N271S and NS) sequences were separated from the plasmid backbones by 
restriction  endonuclease  digestion  and  injected  into  fertilized  oocytes  of 
FVB/N mice to generate transgenic mice (Tg-WT and Tg-NS) according 
to standard procedures. Founder mice were identified by PCR using primers 
specific for the transgene. Level of transgene expression in the different lines 
was compared by Western blot analysis on cardiac tissue using anti-FLAG 
antibody. Founder mice were bred with FVB/N mice and maintained in 
a pathogen-free environment. Experimental protocols were in accordance 
with governmental and institutional guidelines for animal use in research 
and were approved by the Animal Experimentation Commission of the Aca-
demic Medical Center (University of Amsterdam).
Echocardiographic analysis. In the patient, the two-dimensional–para-
sternal short-axis view was obtained at the level of papillary muscles. Wall 
thickness and dimensions were measured from M-mode images using the 
leading-edge method on three consecutive cardiac cycles (Rottman et al., 
2007). RV measurements derived from the clinical study protocol in humans 
(Yoerger et al., 2005) were used to quantify RV size and function.
In vivo cardiac morphology and function was assessed in mice under 
anesthesia (1.5% oxygenated isoflurane inhalation, 37°C body temperature) 
using a mouse transthoracic echocardiography system equipped with a 
30-mHz linear transducer (Vevo770; VisualSonics). Equally aged Tg-NS/H JEM VOL. 206, August 3, 2009 
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